|
|
|
|
FDA Pipeline preview, March 2010 (CPI-300, Ondansetron, Intravenous acetaminophen, Gabapentin enacarbil, Rifax
- - //use referer for server s_linkInternalFilters 'javascript:,.modernmedicine.com' //sitedomaingoeshere site url excluding third level //do not remove (will be provided by Reuben) //do not remove (will be provided by Reuben) //advnstr + _hbxAccount s...
|
|
|
FDA Pipeline preview, March 2010 (CPI-300, Ondansetron, Intravenous acetaminophen, Gabapentin enacarbil, Rifaximin, ENMD-2076, Ap301, CM-AT, Fingolimod, Nilotinib)
Complete response CPI-300 (IntelGenx, Cary Pharmaceuticals) for the treatment of depression.Ondansetron (Zuplenz, Strativa) for preventing nausea and vomiting associated with certain types of chemotherapy, radiotherapy, and surgery. Intravenous...
|
|
|
New treatments for chronic prostatitis/chronic pelvic pain syndrome
Strauss AC et al.Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a common condition among men of a wide age range, with detrimental effects on quality of life. The etiology, pathogenesis, and optimal treatment of CP/CPPS remain unknown,...
|
|
|
Treatments for neuropathic pain differentially affect delayed matching accuracy by macaques: effects of amitri
Current clinical treatments for neuropathic pain include amitriptyline and gabapentin.Since few assessments of cognitive performance have been made in non-human primates with these marketed treatments, these authors aimed to determine their relative...
|
|
|
Low-dose gabapentin as useful adjuvant to opioids for neuropathic cancer pain when combined with low-dose imipramine
Arai YCP et al.Lowdose gabapentinimipramine significantly decreased the total pain score and daily paroxysmal pain episodes. Several patients developed mild adverse symptoms in the four groups, and three patients discontinued treatment due to severe...
|
|
|
Headache Relief Elusive
in Home Remedy Q&A Was this information helpful?100% said yes! (12 votes) What do you think! Click 'thumbs up' or 'thumbs down' to vote! If you have more to say, post a comment below! I am desperate to find a way to relieve my headaches. I...
|
|
|
Effect of preoperative gabapentin on postoperative pain and tramadol consumption after minilap open cholecystectomy: a randomized double-blind, placebo-controlled trial
Srivastava U et al.Effect of preoperative gabapentin on postoperative pain and tramadol consumption after minilap open cholecystectomy: a randomized double-blind, placebo-controlled trial.
|
|
|
Multimodal analgesia with gabapentin, ketamine and dexamethasone in combination with paracetamol and ketorolac after hip arthroplasty: a preliminary study
Rasmussen ML et al.Multimodal analgesia with gabapentin, ketamine and dexamethasone in combination with paracetamol and ketorolac after hip arthroplasty: a preliminary study.
|
|
|
Restructuring Trends Continue in 2010: Exelixis Cuts 270 Jobs
Coming off a rough 2009, during which BioWorld Today reported layoffs at about 85 biotech companies, the industry overall is still looking for ways to cut costs in 2010.The most recent work force reduction is coming to Exelixis Inc., which is laying off 270...
|
|
|
Restructuring Trends Continue in 2010: Exelixis Cuts 270 Jobs
Coming off a rough 2009, during which BioWorld Today reported layoffs at about 85 biotech companies, the industry overall is still looking for ways to cut costs in 2010.The most recent work force reduction is coming to Exelixis Inc., which is laying off 270...
|
|
|
Clinical Setback Forces Restructuring At XenoPort
A clinical setback for XenoPort Inc.(XNPT) could force venture capital firms Maverick Capital and Venrock to wait a while to profit from the $40 million investment they made in the company a little over a year ago. In December 2008, Maverick led and...
|
|
|
Clinical Setback Forces Restructuring At XenoPort
A clinical setback for XenoPort Inc.(XNPT) could force venture capital firms Maverick Capital and Venrock to wait a while to profit from the $40 million investment they made in the company a little over a year ago. In December 2008, Maverick led and...
|
|
|
XenoPort, Inc. (XNPT) Restructures to Focus on Key Programs; Includes An Overall Reduction of 50% of XenoPort'
SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc.(Nasdaq:XNPT) announced today a restructuring that includes an overall reduction in its workforce of approximately 50%. The restructuring is designed to focus the Companys resources on advancement of its...
|
|
|
XenoPort Restructures to Focus on Key Programs
Let the jobs come to you!XenoPort, Inc! (Nasdaq:XNPT) announced today a restructuring that includes an overall reduction in its workforce of approximately 50%. The restructuring is designed to focus the Company?s resources on advancement of its later...
|
|
|
Newsmakers: PGM After Wyeth
Q&A with Tony Maddaluna of Pfizer Global Manufacturing I last spoke with Anthony J.Maddaluna in spring of 2008. Our conversation about Pfizer Global Manufacturing and its years-long process of rationalizing its manufacturing network was published...
|
|
|
XenoPort Cuts Staff, Early R&D After Horizant Blow
XenoPort Inc.is cutting about half its work force and eliminating discovery efforts in the wake of a regulatory setback with restless legs drugs Horizant (gabapentin enacarbil), aiming to focus remaining resources on its late-stage pipeline. The FDA...
|
|
|
XenoPort Restructures to Focus on Key Programs
- XenoPort, Inc.(Nasdaq:XNPT) announced today a restructuring that includes an overall reduction in its workforce of approximately 50%. The restructuring is designed to focus the Company's resources on advancement of its later-stage product candidates.
|
|
|
XenoPort Restructures to Focus on Key Programs
SANTA CLARA, Calif.-- (BUSINESS WIRE) -- XenoPort, Inc.(Nasdaq:XNPT) announced today a restructuring that includes an overall reduction in its workforce of approximately 50%. The restructuring is designed to focus the Companys resources on advancement of...
|
|
|
XenoPort Restructures to Focus on Key Programs - Zibb.com
Company: Xenoport Inc (XNPT) XenoPort, Inc.(Nasdaq:XNPT) announced today a restructuring that includes an overall reduction in its workforce of approximately 50%. The restructuring is designed to focus the Company's resources on advancement of its later...
|
|
|
XenoPort Restructures to Focus on Key Programs
XenoPort, Inc.(Nasdaq:XNPT) announced today a restructuring that includes an overall reduction in its workforce of approximately 50%. The restructuring is designed to focus the Companys resources on advancement of its later-stage product candidates. On...
|
|
|
XenoPort Restructures to Focus on Key Programs
(BUSINESS WIRE) ----XenoPort, Inc.(Nasdaq:XNPT) announced today a restructuring that includes an overall reduction in its workforce of approximately 50%. The restructuring is designed to focus the Company's resources on advancement of its later-stage...
|
|
|
XenoPort Restructures to Focus on Key Programs
(BUSINESS WIRE) ----XenoPort, Inc.(Nasdaq:XNPT) announced today a restructuring that includes an overall reduction in its workforce of approximately 50%. The restructuring is designed to focus the Company's resources on advancement of its later-stage...
|
|
|
XenoPort Restructures to Focus on Key Programs
Companies mentioned in this article: XenoPort, Inc.SANTA CLARA, Calif. -- (BUSINESS WIRE) -- XenoPort, Inc. (Nasdaq:XNPT) announced today a restructuring that includes an overall reduction in its workforce of approximately 50%. The restructuring is...
|
|
|
XenoPort Restructures to Focus on Key Programs
SANTA CLARA, Calif.-- XenoPort, Inc. (Nasdaq:XNPT) announced today a restructuring that includes an overall reduction in its workforce of approximately 50%. The restructuring is designed to focus the Companys resources on advancement of its later-stage...
|
|
|
XenoPort Restructures to Focus on Key Programs
SANTA CLARA, Calif.-- XenoPort, Inc. (Nasdaq:XNPT) announced today a restructuring that includes an overall reduction in its workforce of approximately 50%. The restructuring is designed to focus the Companys resources on advancement of its later-stage...
|
